- Home
- RGLS
RGLS
Regulus Therapeutics Inc.
as 04-18-2025 1:42pm EST
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | N/A | IPO Year: | 2012 |
| Target Price: | $11.80 | AVG Volume (30 days): | 2.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.82 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.83 - $2.90 | Next Earning Date: | 05-08-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Regulus Therapeutics Inc. (RGLS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hagan Joseph P | RGLS | Chief Executive Officer | Jan 30 '25 | Buy | $1.09 | 50,000 | $54,260.00 | 260,808 | |
| BALTIMORE DAVID | RGLS | Director | Jan 30 '25 | Buy | $1.06 | 19,610 | $20,786.60 | 22,169 |
Latest Regulus Therapeutics Inc. News
RGLS Breaking Stock News: Dive into RGLS Ticker-Specific Updates for Smart Investing
PR Newswire
16 days ago
Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit
Simply Wall St.
19 days ago
Regulus Therapeutics Leads The Charge Among 3 Promising Penny Stocks
MT Newswires
22 days ago
Sector Update: Health Care Stocks Advance Late Afternoon
MT Newswires
22 days ago
Top Midday Gainers
MT Newswires
22 days ago
Regulus Therapeutics Completes Phase 1b Farabursen Study in Polycystic Kidney Disease
PR Newswire
23 days ago
Regulus Therapeutics Announces Successful Completion of its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of Farabursen (RGLS8429) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Insider Monkey
a month ago
Regulus Therapeutics (RGLS): One of the Best Short-Term Stocks to Buy Right Now
Simply Wall St.
a month ago
Is Regulus Therapeutics (NASDAQ:RGLS) In A Good Position To Invest In Growth?
Compare RGLS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RGLS Regulus Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.